Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$882K Buy
2,507
+198
+9% +$70.6K 0.44% 53
2025
Q4
$756K Hold
2,309
0.42% 59
2025
Q3
$652K Hold
2,309
0.38% 63
2025
Q2
$645K Hold
2,309
0.4% 54
2025
Q1
$719K Sell
2,309
-2,359
-51% -$697K 0.49% 48
2024
Q4
$1.22M Buy
4,668
+2,334
+100% +$692K 0.39% 62
2024
Q3
$752K Hold
2,334
0.47% 42
2024
Q2
$729K Hold
2,334
0.47% 43
2024
Q1
$664K Hold
2,334
0.4% 54
2023
Q4
$672K Buy
+2,334
New +$636K 0.47% 44

Other funds holding AMGN

Hara Capital's AMGN Position: Q1 2026 in Review

Hara Capital increased its Amgen (AMGN) stake by 8.6% in Q1 2026, buying an estimated $70.6K and bringing the position to 2,507 shares worth $882K. The position accounts for 0.44% of the portfolio, ranked #53.

Hara Capital first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.22M in Q4 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Hara Capital held 2,507 shares of Amgen worth $882K as of Q1 2026.
  • Hara Capital bought 198 Amgen shares in Q1 2026, an estimated $70.6K.
  • Amgen made up 0.44% of Hara Capital's portfolio in Q1 2026, its #53 holding.
  • Hara Capital first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • Hara Capital's Amgen position peaked at $1.22M in Q4 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.